Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v2-EN
Language French English
Date Updated 2020-04-14 2019-08-14
Drug Identification Number 02376601 02376601
Brand name EXTRA STRENGTH IBUPROFEN LIQUID GEL CAPSULES EXTRA STRENGTH IBUPROFEN LIQUID GEL CAPSULES
Common or Proper name IBUPROFEN IBUPROFEN
Company Name APOTEX INC APOTEX INC
Ingredients IBUPROFEN IBUPROFEN
Strength(s) 400MG 400MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 50 BTL 50 BTL
ATC code M01AE M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-08-13 2019-08-13
Estimated end date 2020-04-10 Unknown
Actual end date 2020-04-10
Shortage status Resolved Actual shortage
Company comments
Health Canada comments